Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[High bioactive material-bone graft in bone defect healing]

Jun Lin1, Hui-Ming Wang, Zhi-Qinag Cao

  • 1The First Affiliated Hospital, College of Medical Sciences, Zhejiang University, Hangzhou 310003, China.

Zhejiang Da Xue Xue Bao. Yi Xue Ban = Journal of Zhejiang University. Medical Sciences
|January 31, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Breaking Through the Bottleneck of Wireless Physical-Layer Key Generation by Dynamic Agile Reconfigurable Intelligent Surface Antenna (DARISA).

Entropy (Basel, Switzerland)·2026
Same author

Antibody-drug conjugates specifically regulate tumor microenvironment: A promising strategy for pancreatic cancer treatment.

Hepatobiliary & pancreatic diseases international : HBPD INT·2025
Same author

Locking Orbital Angular Momentum with Linear Momentum of Light.

Physical review letters·2025
Same author

Autonomous microfluidic influenza A/B subtyping system using on-chip multiplex isothermal amplification for field-deployable surveillance.

AMB Express·2025
Same author

Humanized dual-targeting antibody-drug conjugates specific to MET and RON receptors as a pharmaceutical strategy for the treatment of cancers exhibiting phenotypic heterogeneity.

Acta pharmacologica Sinica·2025
Same author

Difference in summer heatwave-induced damage between desert native and urban greening plants in an arid desert region.

PloS one·2024

Hydroxyapatite (HA) combined with TGF-beta1 significantly enhances bone defect healing by promoting type I collagen mRNA levels. This bioactive material effectively bonds with new bone growth, outperforming HA granules alone.

Area of Science:

  • Biomaterials Science
  • Regenerative Medicine
  • Orthopedic Research

Background:

  • Bone defects pose significant clinical challenges.
  • Hydroxyapatite (HA) is a common bone graft substitute.
  • Growth factors can enhance bone regeneration.

Purpose of the Study:

  • To evaluate the efficacy of bioactive material-HA combined with TGF-beta1 in bone defect healing.
  • To compare this combination therapy against HA granules alone and ungrafted defects.

Main Methods:

  • Utilized a Sprague Dawley (SD) rat model for bone defect creation.
  • Administered HA granules combined with TGF-beta1 (Group A).
  • Compared outcomes with HA granules alone (Group B) and untreated defects (Group C).

Related Experiment Videos

Main Results:

  • Group A exhibited the highest expression of type I collagen mRNA during the healing period.
  • The combination of HA and TGF-beta1 demonstrated superior bone bonding capabilities.

Conclusions:

  • Bioactive material-HA combined with TGF-beta1 is a promising therapeutic strategy for bone defect healing.
  • This combination promotes enhanced new bone formation and integration.
  • TGF-beta1 significantly augments the osteoconductive properties of HA granules.